secwatch / observer
8-K filed January 2, 2026, 6:59 PM ET ticker USAQ CIK 0000856984
other material confidence high sentiment neutral materiality 0.45

QHSLab converts $126,548 of note into 421,827 shares; extends remaining $20k to Dec 2026

QHSLab, Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

QHSLab, Inc. issued 421,827 shares of common stock to Alex Mirakian MD PA for conversion of $126,548 of principal and accrued interest at $0.30 per share.

Security
common stock
Shares
421,827 shares
Purchaser
Alex Mirakian MD PA
Consideration
conversion of $126,548 of principal and accrued interest at $0.30 per share
Exact text from the filing
the Company issued 421,827 shares of its common stock to Alex Mirakian MD PA in exchange for the conversion of $126,548 of principal and accrued interest under the Original Note. The shares were issued at an effective price of $0.30 per share.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

QHSLab, Inc. amended Promissory Note Modification and Partial Conversion Agreement with Alex Mirakian MD PA (effective 2025-12-31).

Action
amendment
Counterparty
Alex Mirakian MD PA
Effective
2025-12-31
Exact text from the filing
On December 31, 2025, QHSLab, Inc., (the Company), entered into a Promissory Note Modification and Partial Conversion Agreement (the Modification Agreement) with Alex Mirakian MD PA (the Holder), in connection with a previously issued convertible promissory note dated May 7, 2021 (the Original Note).
View on SEC.gov

Browse all equity issuances →

QHSLab, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-26-000092
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.